CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Hospital Anxiety and Depression Scale (HADS) questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02122406
NCT02122406N/ACompleted
CompareCT.gov

Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity

University of Pavia·observational·Posted Apr 24, 2014·Updated Oct 10, 2016

In Brief

An observational study evaluating Hospital Anxiety and Depression Scale (HADS) questionnaire for Rheumatoid Arthritis and 2 related conditions. Completed, enrolled 200 participants across 1 site.

Detailed Summary

The primary endpoint of this study is to evaluate the prevalence of anxiety and depressive disorders, and their relationship with disease activity, in patients with rheumatoid arthritis treated with biological drugs

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis, Depression, Anxiety
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 24, 2014
Enrollment StartJan 1, 2014
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.2 years ago

Interventions

Hospital Anxiety and Depression Scale (HADS) questionnaireother

Patients filled in the Hospital Anxiety and Depression Scale (HADS) questionnaire